Hasil Pencarian - Meera Mohan
- Menampilkan 1 - 11 hasil dari 11
-
1
-
2
-
3
Gender disparities in multiple myeloma publications oleh Aala Dweik, Hadeel Dweik, Hira Mian, Meera Mohan, Carolina Schinke, Samer Al Hadidi
Diterbitkan 2022-08-01Dapatkan teks lengkap
Artikel -
4
Outcomes of VDPACE with an immunomodulatory agent as a salvage therapy in relapsed/refractory multiple myeloma with extramedullary disease oleh Al‐Ola Abdallah, Ghulam Rehman Mohyuddin, Nausheen Ahmed, Meera Mohan, Wei Cui, Leyla Shune, Zahra Mahmoudjafari, Joseph McGuirk, Siddhartha Ganguly, Shebli Atrash
Diterbitkan 2021-11-01Dapatkan teks lengkap
Artikel -
5
Black patients with multiple myeloma have better survival than white patients when treated equally: a matched cohort study oleh Jing Dong, Zhuping Garacci, Christopher Staffi Buradagunta, Anita D’Souza, Meera Mohan, Ashley Cunningham, Siegfried Janz, Binod Dhakal, Aaron P. Thrift, Parameswaran Hari
Diterbitkan 2022-02-01Dapatkan teks lengkap
Artikel -
6
Adverse effects and non-relapse mortality of BCMA directed T cell therapies in multiple myeloma: an FAERS database study oleh Zimu Gong, Godsfavour Umoru, Jorge Monge, Nishi Shah, Ghulam Rehman Mohyuddin, Sabarinath Venniyil Radhakrishnan, Rajshekhar Chakraborty, Leo Rasche, Carolina Schinke, Anita D’Souza, Meera Mohan
Diterbitkan 2024-03-01Dapatkan teks lengkap
Artikel -
7
Alterations in chromosome 1q in multiple myeloma randomized clinical trials: a systematic review oleh Karun Neupane, Gliceida Galarza Fortuna, Riyasha Dahal, Timothy Schmidt, Rafael Fonseca, Rajshekhar Chakraborty, Kelly Ann Koehn, Meera Mohan, Hira Mian, Luciano J. Costa, Douglas Sborov, Ghulam Rehman Mohyuddin
Diterbitkan 2024-01-01Dapatkan teks lengkap
Artikel -
8
Sustained remission following finite duration bispecific antibody therapy in patients with relapsed/refractory myeloma oleh Rajshekhar Chakraborty, Heloise Cheruvalath, Anannya Patwari, Aniko Szabo, Carolina Schinke, Binod Dhakal, Suzanne Lentzsch, Anita D’Souza, Ghulam Rehman Mohyuddin, Kelley Julian, Shonali Midha, Patrick Costello, Martin Kaiser, Melissa Ng Liet Hing, Simon J. Harrison, Edward R. Scheffer Cliff, Meera Mohan
Diterbitkan 2024-08-01Dapatkan teks lengkap
Artikel -
9
Teclistamab in relapsed refractory multiple myeloma: multi-institutional real-world study oleh Meera Mohan, Jorge Monge, Nishi Shah, Danny Luan, Mark Forsberg, Vineel Bhatlapenumarthi, Metodi Balev, Anannya Patwari, Heloise Cheruvalath, Divaya Bhutani, Sharmilan Thanendrarajan, Binod Dhakal, Maurizio Zangari, Samer Al-Hadidi, Dennis Cooper, Suzanne Lentzsch, Frits van Rhee, Anita D’Souza, Aniko Szabo, Carolina Schinke, Rajshekhar Chakraborty
Diterbitkan 2024-03-01Dapatkan teks lengkap
Artikel -
10
The changing spectrum of infection with BCMA and GPRC5D targeting bispecific antibody (bsAb) therapy in patients with relapsed refractory multiple myeloma oleh Lindsay Hammons, Aniko Szabo, Abhishek Janardan, Vineel Bhatlapenumarthi, Evanka Annyapu, Binod Dhakal, Samer Al Hadidi, Sabarinath Venniyil Radhakrishnan, Ravi Narra, Divaya Bhutani, Sharmilan Thanendrarajan, Siegfried Janz, Maurizio Zangari, Suzanne Lentzsch, Frits van Rhee, Juan Carlos Rico Crescencio, Anita D’Souza, Rajshekhar Chakraborty, Meera Mohan, Carolina Schinke
Diterbitkan 2023-08-01Dapatkan teks lengkap
Artikel -
11
The prognostic value of the depth of response in multiple myeloma depends on the time of assessment, risk status and molecular subtype oleh Carolina Schinke, Antje Hoering, Hongwei Wang, Victoria Carlton, Sharmilan Thanandrarajan, Shayu Deshpande, Purvi Patel, Gabor Molnar, Sandra Susanibar, Meera Mohan, Pankaj Mathur, Muthukumar Radhakrishnan, Shadiqul Hoque, Jorge Jo Kamimoto, Monica Grazziutti, Frits van Rhee, Maurizio Zangari, Giovanni Insuasti-Beltran, Daisy Alapat, Ginell Post, Shmuel Yaccoby, Joshua Epstein, Leo Rasche, Sarah Johnson, Martin Moorhead, Tom Willis, Bart Barlogie, Brian Walker, Niels Weinhold, Faith E Davies, Gareth J. Morgan
Diterbitkan 2017-08-01Dapatkan teks lengkap
Artikel